{"url_path":"/sec/pgen/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1356090/0001356090-26-000017-index.html","accession_number":"0001356090-26-000017","cik":"0001356090","ticker":"PGEN","issuer_name":"PRECIGEN, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1356090/0001356090-26-000017-index.html","primary_entity_key":"0001356090","primary_entity_name":"PRECIGEN, INC."},"word_count":118,"has_tables":true,"body_markdown":"Item 1. Legal Proceedings\n\nIn the course of our business, we are involved in litigation or legal matters, including governmental investigations. Such matters are subject to many uncertainties and outcomes are not predictable with assurance. We accrue liabilities for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. As of March 31, 2026, we do not believe that any such matters, individually or in the aggregate, will have a material adverse effect on our business, financial condition, results of operations, or cash flows.\n\nSee \"Notes to the Condensed Consolidated Financial Statements (Unaudited) - Note 14\" appearing elsewhere in this Quarterly Report for further discussion of ongoing legal matters."}